文献速递关节外科

肥胖与非肥胖患者单髁膝关节置换术后生存率和患者报告结局相当:一项更新的系统评价

Comparable Survivorship and Patient-Reported Outcomes Following Unicompartmental Knee Arthroplasty in Obese and Nonobese Patients: An Updated Systematic Review.
PubMed 文献 · J Arthroplasty · 2026-06-18

该系统评价纳入27项研究共27,271膝,比较非肥胖、肥胖和病态肥胖患者单髁膝关节置换术(UKA)后的生存率、翻修原因和患者报告结局(PROMs)。结果显示各BMI组5年以内生存率无差异,5至10年生存率有差异但病态肥胖与非肥胖比较无显著差异,10年以上生存率无差异;肥胖不应视为UKA的绝对禁忌证,病态肥胖患者因关节炎进展需二次手术更多,但为可改变的风险因素。

要点

  • 肥胖患者UKA术后生存率在<5年、5-<10年和≥10年随访中与非肥胖患者相当。
  • 病态肥胖患者因骨关节炎进展和技术相关失败需二次手术的比例更高。
  • 所有BMI类别PROMs均改善,肥胖和病态肥胖者评分略低。

核心结论

  • 肥胖不应被视为UKA的绝对禁忌证。
  • 肥胖患者获得显著功能改善,且生存率在<5年、5-<10年和≥10年随访中与非肥胖患者相当。
  • 病态肥胖患者更常因关节炎进展需二次手术,此为可改变的风险因素,可用于个体化术前咨询和风险缓解策略。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、EMBASE和CENTRAL从建库至2025年10月15日。
  • 纳入27项研究共27,271膝,平均年龄65岁,平均BMI 30.7。
  • 按BMI分层:非肥胖(BMI<30)、肥胖(BMI 30至<40)和病态肥胖(BMI≥40)。
  • 比较<5年、5至<10年和≥10年生存率,以及翻修原因和PROMs。
  • 证据等级IV。

主要发现

  • <5年生存率:非肥胖95.5%、肥胖95.3%、病态肥胖95.8%(P=0.943)。
  • 5至<10年生存率:非肥胖95.3%、肥胖92.1%、病态肥胖90.6%(P=0.034),调整后两两比较病态肥胖与非肥胖无显著差异(调整P=0.065)。
  • ≥10年生存率:非肥胖92.1%、肥胖92.9%、病态肥胖88.7%(P=0.460)。
  • 最常见翻修原因:无菌性松动(47.0%)、无松动疼痛(16.2%)、骨关节炎进展(15.2%)。
  • 病态肥胖患者骨关节炎进展和技术相关失败率更高;所有BMI类别PROMs均改善,肥胖和病态肥胖者评分略低。

关键数值与推荐

  • 非肥胖定义为BMI<30,肥胖为BMI 30至<40,病态肥胖为BMI≥40。
  • 肥胖组和非肥胖组在<5年、5至<10年和≥10年随访中生存率相当。
  • 病态肥胖组5至<10年生存率90.6%低于非肥胖组95.3%(P=0.034),但调整后比较无显著差异(调整P=0.065)。

临床怎么用

  • 肥胖患者可考虑UKA,不应仅因肥胖而排除手术。
  • 术前咨询应告知病态肥胖患者因关节炎进展需二次手术的风险较高。
  • 针对病态肥胖患者可制定个体化风险缓解策略,如体重管理。

局限性

  • 证据等级IV,纳入研究多为观察性研究,可能存在混杂偏倚。
  • 病态肥胖组与非肥胖组5至<10年生存率调整后比较无显著差异,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The influence of obesity on outcomes after unicompartmental knee arthroplasty (UKA) remains controversial. This systematic review evaluated whether obesity affects survivorship, reasons for revision, and patient-reported outcome measures (PROMs) following UKA. METHODS: MEDLINE, EMBASE, and CENTRAL were searched from inception to October 15, 2025. Eligible studies reported UKA outcomes stratified by body mass index (BMI), including cohorts exclusively composed of obese patients (BMI ≥ 30). Less than 5-year), five to less than 10-year, and ≥ 10-year survivorship was compared across nonobese (BMI less than 30), obese (BMI 30 to less than 40), and morbidly obese (BMI ≥ 40) patients using meta-analysis. Secondary outcomes included reasons for revision and PROMs. There were 27 studies (27,271 knees) included (mean age, 65 years; mean BMI, 30.7). RESULTS: Less than 5-year survivorship for nonobese, obese, and morbidly obese groups was 95.5, 95.3, and 95.8%, respectively (P = 0.943). The five to less than 10-year survivorship was 95.3, 92.1, and 90.6%, respectively (P = 0.034), with adjusted pairwise comparison demonstrating a nonsignificant trend toward lower survivorship in morbidly obese patients compared to nonobese (adjusted P = 0.065). The ≥ 10-year survivorship was 92.1, 92.9, and 88.7%, respectively (P = 0.460). The most common causes for revision were aseptic loosening (47.0%), pain without loosening (16.2%), and progression of osteoarthritis (15.2%). Morbidly obese patients demonstrated higher rates of progressive osteoarthritis and technique-related failure. The PROMs improved across all BMI categories, with slightly lower scores in obese and morbidly obese individuals. CONCLUSIONS: Obesity should not be considered an absolute contraindication to UKA. Obese patients achieve substantial functional improvement and demonstrate survivorship comparable to nonobese patients across less than 5-years, five to less than 10-years, and ≥ 10-years follow-up. Morbidly obese patients more often required secondary surgery for progression of arthritis, a modifiable risk factor that can inform individualized preoperative counseling and risk mitigation strategies. LEVEL OF EVIDENCE: IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Cruickshank M, Son H, Abdel Khalik H, et al. Comparable Survivorship and Patient-Reported Outcomes Following Unicompartmental Knee Arthroplasty in Obese and Nonobese Patients: An Updated Systematic Review. J Arthroplasty. 2026. PMID: 42315061. doi:10.1016/j.arth.2026.06.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。